Literature DB >> 25427905

TLR4-dependent tumor-initiating stem cell-like cells (TICs) in alcohol-associated hepatocellular carcinogenesis.

Keigo Machida1, Douglas E Feldman, Hidekazu Tsukamoto.   

Abstract

Alcohol abuse predisposes individuals to the development of hepatocellular carcinoma (HCC) and synergistically heightens the HCC risk in patients infected with hepatitis C virus (HCV). The mechanisms of this synergism have been elusive until our recent demonstration of the obligatory role of ectopically expressed TLR4 in liver tumorigenesis in alcohol-fed HCV Ns5a or Core transgenic mice. CD133+/CD49f+ tumor-initiating stem cell-like cells (TICs) isolated from these models are tumorigenic in a manner dependent on TLR4 and NANOG. TICs' tumor-initiating activity and chemoresistance are causally associated with inhibition of TGF-β tumor suppressor pathway due to NANOG-mediated expression of IGF2BP3 and YAP1. TLR4/NANOG activation causes p53 degradation via phosphorylation of the protective protein NUMB and its dissociation from p53 by the oncoprotein TBC1D15. Nutrient deprivation reduces overexpressed TBC1D15 in TICs via autophagy-mediated degradation, suggesting a possible role of this oncoprotein in linking metabolic reprogramming and self-renewal.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25427905     DOI: 10.1007/978-3-319-09614-8_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  9 in total

1.  NUMB phosphorylation destabilizes p53 and promotes self-renewal of tumor-initiating cells by a NANOG-dependent mechanism in liver cancer.

Authors:  Hifzur R Siddique; Douglas E Feldman; Chia-Lin Chen; Vasu Punj; Hiroshi Tokumitsu; Keigo Machida
Journal:  Hepatology       Date:  2015-08-28       Impact factor: 17.425

Review 2.  Innate immunity and hepatocarcinoma: Can toll-like receptors open the door to oncogenesis?

Authors:  Jorge André Gomes Lopes; Marta Borges-Canha; Pedro Pimentel-Nunes
Journal:  World J Hepatol       Date:  2016-01-28

Review 3.  Involvement of inflammation and its related microRNAs in hepatocellular carcinoma.

Authors:  Ke Jin; Tong Li; Gonzalo Sánchez-Duffhues; Fangfang Zhou; Long Zhang
Journal:  Oncotarget       Date:  2017-03-28

Review 4.  Role of cytokines and chemokines in alcohol-induced tumor promotion.

Authors:  Danlei Chen; Fengyun Zhang; Haifeng Ren; Jia Luo; Siying Wang
Journal:  Onco Targets Ther       Date:  2017-03-17       Impact factor: 4.147

5.  Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis.

Authors:  Ningrui Bi; Yuanmei Sun; Shan Lei; Zhirui Zeng; Yan Zhang; Chengyi Sun; Chao Yu
Journal:  Oncol Rep       Date:  2020-06-05       Impact factor: 3.906

Review 6.  Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma.

Authors:  Xiaomeng Dai; Yixuan Guo; Yan Hu; Xuanwen Bao; Xudong Zhu; Qihan Fu; Hangyu Zhang; Zhou Tong; Lulu Liu; Yi Zheng; Peng Zhao; Weijia Fang
Journal:  Theranostics       Date:  2021-01-19       Impact factor: 11.556

7.  Identification and Validation of HCC-specific Gene Transcriptional Signature for Tumor Antigen Discovery.

Authors:  Annacarmen Petrizzo; Francesca Pia Caruso; Maria Tagliamonte; Maria Lina Tornesello; Michele Ceccarelli; Valerio Costa; Marianna Aprile; Roberta Esposito; Gennaro Ciliberto; Franco M Buonaguro; Luigi Buonaguro
Journal:  Sci Rep       Date:  2016-07-08       Impact factor: 4.379

8.  M2-polarized tumor-associated macrophages facilitated migration and epithelial-mesenchymal transition of HCC cells via the TLR4/STAT3 signaling pathway.

Authors:  Rong-Rong Yao; Jing-Huan Li; Rui Zhang; Rong-Xin Chen; Yan-Hong Wang
Journal:  World J Surg Oncol       Date:  2018-01-16       Impact factor: 2.754

9.  Single-cell omics analysis reveals functional diversification of hepatocytes during liver regeneration.

Authors:  Tianyi Chen; Sehhoon Oh; Simon Gregory; Xiling Shen; Anna Mae Diehl
Journal:  JCI Insight       Date:  2020-11-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.